The Use of a Combination of Vaccinium Macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the Prevention of Chronic Bacterial Prostatitis: A Double-Blind Randomized Study.
- 2019
- RCT · n = 120
- Urologia internationalis 103(4)
- Francesco Chiancone
- Maurizio Carrino
- Clemente Meccariello
- Luigi Pucci
- Maurizio Fedelini
- Paolo Fedelini
- PubMed: 31527377
- DOI: 10.1159/000502765
- High evidence
- Large Human Trial
- Clinical
The patients of the Group A experienced a significantly larger reduction in the prostatitis episodes than the Group B at 24 and 36 weeks, but they did not experience a significantly larger reduction at 12 weeks.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 320 mg/day